Latest Revenue Forecast News

Page 3 of 18
Atomo Diagnostics has signed an MOU with Innovation Scientific to develop a fourth-generation HIV rapid test using its Galileo cassette. The project could add a new product to Atomo’s pipeline, but regulatory approval, clinical work and definitive commercial agreements remain outstanding.
Ada Torres
Ada Torres
29 Oct 2026
Me Today says more than 80% of its Series 1 warrants have been exercised, delivering $2.31 million of new capital as the nutraceuticals company forecasts stronger first-half FY27 revenue. FY26 gross revenue rose 36% to $7.96 million while the EBITDA loss narrowed substantially.
Victor Sage
Victor Sage
29 Oct 2026
Elsight delivered US$25.8 million in unaudited revenue for the first nine months of 2026, up 91% on the prior corresponding period, but a weaker-than-expected third quarter produced a non-GAAP loss. The company is relying on expanded US defence procurement access, new products and a US$196 million opportunity pipeline to support future growth.
Victor Sage
Victor Sage
28 Oct 2026
PARKD’s FY26 annual report puts the company’s funding position under sharper scrutiny after a steep revenue decline, a $1.26 million loss and $367,714 in cash. Its east-coast expansion produced new facilities, partnerships and demonstrations, but the next test is converting that platform into contracted work quickly enough.
Victor Sage
Victor Sage
28 Oct 2026
Adheris Health delivered a stronger first quarter on revenue, margins and its CY27 sales pipeline, but ended September with US$3.5 million in cash after a US$3.1 million operating outflow. The company also disclosed the impending loss of a major pharmacy partner and a US$2.3 million-plus legal claim.
Ada Torres
Ada Torres
28 Oct 2026
Nova Minerals has secured the final approvals needed to build and operate its integrated Alaska antimony project, removing a major regulatory hurdle ahead of targeted 2027 production. The US$43.4 million Phase 1 program is funded and equipped, but the company has not yet disclosed production volumes, costs or a detailed construction schedule.
Maxwell Dee
Maxwell Dee
28 Oct 2026
Lunnon Metals has completed its first open pit broadly in line with feasibility expectations, lifting cash to $43 million and generating about $39 million in pre-tax free cash flow. The ASX-listed miner now faces a more speculative phase as it spends $13 million testing gold targets and weighs a possible return to nickel.
Maxwell Dee
Maxwell Dee
28 Oct 2026
Botanix’s Sofdra prescriptions rose 5.3% in the September quarter, but flat net revenue and a sharp cash decline have forced a major reset. The company is targeting a roughly 50% reduction in operating expenses while assessing licensing, acquisitions and broader strategic transactions.
Victor Sage
Victor Sage
27 Oct 2026
GR Engineering Services delivered stronger FY26 earnings and lifted its dividend, but the scale of its new project pipeline is bringing a substantial working-capital requirement. The ASX-listed contractor is forecasting FY27 revenue of A$825 million to A$850 million after securing more than A$1 billion in contracts since April.
Victor Sage
Victor Sage
26 Oct 2026
IKE has lowered its previously indicated FY27 subscription revenue growth expectation of about 35%, citing contract timing rather than weaker demand or churn. The NZX and ASX-listed software company still expects its subscription exit run rate to grow by more than 30% by March 2027, while three new products remain on track for launch.
Sophie Babbage
Sophie Babbage
23 Oct 2026
CSL has been named as the defendant in a group proceeding filed in the Supreme Court of Victoria, covering investors who acquired certain securities between February 2025 and May 2026. The company denies liability and says it will vigorously defend allegations involving continuous disclosure and FY26 performance statements.
Ada Torres
Ada Torres
22 Oct 2026
AEMO has increased the capacity allocation for Frontier Energy’s Waroona Stage One project by 10.95MW, lifting expected annual Reserve Capacity Payments to about $36 million. The change raises the project’s forecast revenue, EBITDA and free cash flow through the fixed-price period, although the forecasts still depend on construction, commissioning and future capacity assessments.
Victor Sage
Victor Sage
21 Oct 2026

Browse the archive

Full archive